These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 9568683)

  • 1. Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment.
    Tang-Christensen M; Vrang N; Larsen PJ
    Diabetes; 1998 Apr; 47(4):530-7. PubMed ID: 9568683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats.
    Larsen PJ; Fledelius C; Knudsen LB; Tang-Christensen M
    Diabetes; 2001 Nov; 50(11):2530-9. PubMed ID: 11679431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.
    Larsen PJ; Tang-Christensen M; Jessop DS
    Endocrinology; 1997 Oct; 138(10):4445-55. PubMed ID: 9322962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-like peptide containing pathways in the regulation of feeding behaviour.
    Tang-Christensen M; Vrang N; Larsen PJ
    Int J Obes Relat Metab Disord; 2001 Dec; 25 Suppl 5():S42-7. PubMed ID: 11840214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake.
    Navarro M; Rodriquez de Fonseca F; Alvarez E; Chowen JA; Zueco JA; Gomez R; Eng J; Blázquez E
    J Neurochem; 1996 Nov; 67(5):1982-91. PubMed ID: 8863504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats.
    Tang-Christensen M; Larsen PJ; Göke R; Fink-Jensen A; Jessop DS; Møller M; Sheikh SP
    Am J Physiol; 1996 Oct; 271(4 Pt 2):R848-56. PubMed ID: 8897973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of neuropeptide Y on drinking in mice.
    Morley JE; Flood JF
    Brain Res; 1989 Aug; 494(1):129-37. PubMed ID: 2765911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of CNS glucagon-like peptide-1 (7-36) amide receptors in mediating the visceral illness effects of lithium chloride.
    Seeley RJ; Blake K; Rushing PA; Benoit S; Eng J; Woods SC; D'Alessio D
    J Neurosci; 2000 Feb; 20(4):1616-21. PubMed ID: 10662851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for glucagon-like peptide-1 in the central regulation of feeding.
    Turton MD; O'Shea D; Gunn I; Beak SA; Edwards CM; Meeran K; Choi SJ; Taylor GM; Heath MM; Lambert PD; Wilding JP; Smith DM; Ghatei MA; Herbert J; Bloom SR
    Nature; 1996 Jan; 379(6560):69-72. PubMed ID: 8538742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide-1 (7-36) amide administered into the third cerebroventricle inhibits water intake in rats.
    Wang T; Edwards GL; Baile CA
    Proc Soc Exp Biol Med; 1998 Oct; 219(1):85-91. PubMed ID: 9751227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postnatal MSG treatment attenuates angiotensin II (AII) induced drinking in rats.
    Caputo FA; Scallet AC
    Physiol Behav; 1995 Jul; 58(1):25-9. PubMed ID: 7667423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats.
    McMahon LR; Wellman PJ
    Am J Physiol; 1998 Jan; 274(1):R23-9. PubMed ID: 9458894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The arcuate nucleus is pivotal in mediating the anorectic effects of centrally administered leptin.
    Tang-Christensen M; Holst JJ; Hartmann B; Vrang N
    Neuroreport; 1999 Apr; 10(6):1183-7. PubMed ID: 10363921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central but not peripheral glucoprivation is impaired in monosodium glutamate-treated rats.
    de Andrade IS; Gonzalez JC; Hirata AE; Carneiro G; Amado D; Cavalheiro EA; Dolnikoff MS
    Neurosci Lett; 2006 May; 398(1-2):6-11. PubMed ID: 16406310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-related stimulation of feeding by systemic injections of monosodium glutamate.
    Reddy VM; Meharg SS; Ritter S
    Physiol Behav; 1986 Oct; 38(4):465-9. PubMed ID: 3823160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Food deprivation-induced changes in body fat mobilization after neonatal monosodium glutamate treatment.
    Leitner C; Bartness TJ
    Am J Physiol Regul Integr Comp Physiol; 2008 Mar; 294(3):R775-83. PubMed ID: 18094070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foetal proglucagon processing in relation to adult appetite control: lessons from a transplantable rat glucagonoma with severe anorexia.
    Jensen PB; Larsen PJ; Karlsen C; Jensen HI; Holst JJ; Madsen OD
    Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():60-8. PubMed ID: 21824258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ghrelin stimulates GH but not food intake in arcuate nucleus ablated rats.
    Tamura H; Kamegai J; Shimizu T; Ishii S; Sugihara H; Oikawa S
    Endocrinology; 2002 Sep; 143(9):3268-75. PubMed ID: 12193538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of orexigenic counter-regulation for multiple targeted feeding inhibition.
    Schusdziarra V; Zimmermann JP; Schick RR
    Obes Res; 2004 Apr; 12(4):627-32. PubMed ID: 15090630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of neuropeptide Y receptors in the hypothalamus of monosodium glutamate-lesioned Sprague-Dawley rats.
    Stricker-Krongrad A; Beck B
    Nutr Neurosci; 2004 Aug; 7(4):241-5. PubMed ID: 15682651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.